Therapy News and Research

RSS

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

12 Sep 2004

Treatment with vitamin A and an omega-3 fatty acid slows down the progression of retinitis pigmentosa

Patients with retinitis pigmentosa, a progressive eye disease that can cause vision loss, who were treated with vitamin A and docosahexaenoic acid (DHA), a kind of omega-3 fatty acid, did not experience slowing of the progression of their disease

12 Sep 2004

New genetic test can predict cleft lip or palate

Researchers have developed a new genetic test that can help predict whether parents who have one child with the "isolated" form of cleft lip or palate are likely to have a second child with the same birth defect. Isolated clefts account for 70 percent of all cleft lip and palate cases.

10 Sep 2004

Grant to study genetics and drug interaction

A University of Minnesota researcher received a nearly $1 million grant from the National Institutes of Health (NIH) to study how genetic differences affect whether people will experience dangerous drug interactions and how to adjust medications to avoid those interactions.

10 Sep 2004

Smallest patient to receive surgery to correct an abdominal disorder using an advanced surgical robotic system

After spending more than seven months in the hospital following his premature birth, the parents of Dakota Templeton were hopeful that his worst medical challenges were behind him. Unfortunately, those hopes were not realized.

10 Sep 2004

Disruption of protein folding causes neurodegeneration, mental retardation

Excess accumulation in brain cells of a fat molecule called GM1-ganglioside (GM1) disrupts the folding of newly assembled proteins into their proper shapes, triggering nerve degeneration and mental retardation in children.

10 Sep 2004

Transthyretin discovery may halt progression of Alzheimer's

In a finding that may cause a dramatic shift in the way scientists and researchers search for a therapy for Alzheimer's disease, a team of researchers led by Jeff Johnson, an associate professor at the School of Pharmacy, has discovered that increased expression of a protein called transthyretin in the brain appears to halt the progression of the disease.

10 Sep 2004

Magnetic resonance imaging helps measure osteoarthritis

Researchers from Australia's Monash University have revolutionised knee scans with the development of new technology that harnesses the power of magnetic resonance imaging (MRI).

10 Sep 2004

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

Scientists at the University of Edinburgh are closer to correcting an abnormal gene which causes one of the crippling muscle wasting diseases known collectively as Charcot-Marie-Tooth (CMT) disease.

10 Sep 2004

New treatment for T-cell acute lymphoblastic leukaemia

IL-7, a hormone-like protein involved in cell-cell interaction, has been associated with increased survival and expansion of T-cell acute lymphoblastic leukaemia (T-ALL).

9 Sep 2004

Revised draft Mental Health Bill

The British Government has today published a revised draft Mental Health Bill. The Bill will be subject to pre-legislative scrutiny by a parliamentary committee, which has been asked to present its report by the end of March 2005.

8 Sep 2004

Depressed patients may need treatment for both physical and emotional symptoms

Physical symptoms (such as headache, back pain, stomach problems, joint or muscle pains, and dizziness) are nearly as common in depression as emotional symptoms and are the predominant complaint depressed patients present with in the primary care setting.

8 Sep 2004

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Gene therapy that causes the bladder to act like a “bioreactor” to produce and secrete the anti-cancer agent interferon-alpha has shown dramatic benefits in preclinical tests, say researchers at The University of Texas M. D. Anderson Cancer Center.

8 Sep 2004

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Controlling diarrhoea and constipation in autistic children without using antibiotics

Scientists checking bacteria which live in the intestines of autistic children may have found a way to control gut problems, such as diarrhoea or constipation, without using antibiotics

8 Sep 2004

Pioneering work with human embryonic stem cells could speed up development of new treatments for Parkinson’s and diabetes

Pioneering work with human embryonic stem (hES) cells could speed up the development of new treatments for a range of degenerative disorders such as Parkinson’s disease and diabetes according to Dr Stephen Minger of King’s College London, speaking today at the BA Festival of Science.

8 Sep 2004

Research into constraint-induced movement therapy

Traditional treatment of movement problems for people who have suffered traumatic brain injury or strokes has mainly focused on making the best use of motor functions the patient has retained.

8 Sep 2004

Pig tissue may help reduce the damage and disability of stroke

A tiny capsule containing tissue that secretes a cocktail of brain-nourishing neurotrophic factors may one day help reduce the damage and disability of stroke, according to research published in the September issue of Stroke.

7 Sep 2004

Ramipril reduces rate of sudden cardiac death and nonfatal cardiac arrest by 21 percent

Ramipril, a high blood pressure and heart failure drug, can reduce the rate of sudden cardiac death and nonfatal cardiac arrest by 21 percent in people at high risk for heart attack or stroke, according to a study reported in Circulation: Journal of the American Heart Association.

7 Sep 2004

Therapy News and Research

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Treatment with vitamin A and an omega-3 fatty acid slows down the progression of retinitis pigmentosa

New genetic test can predict cleft lip or palate

Grant to study genetics and drug interaction

Smallest patient to receive surgery to correct an abdominal disorder using an advanced surgical robotic system

Disruption of protein folding causes neurodegeneration, mental retardation

Transthyretin discovery may halt progression of Alzheimer's

Magnetic resonance imaging helps measure osteoarthritis

Scientists closer to correcting an abnormal gene which causes Charcot-Marie-Tooth disease

New treatment for T-cell acute lymphoblastic leukaemia

Revised draft Mental Health Bill

Depressed patients may need treatment for both physical and emotional symptoms

Gene therapy holds much promise for treating aggressive human superficial bladder cancer

Researchers uncover how HIV causes abnormalities in antibody-producing cells

Cymbalta approved for diabetic peripheral neuropathy pain

Controlling diarrhoea and constipation in autistic children without using antibiotics

Pioneering work with human embryonic stem cells could speed up development of new treatments for Parkinson’s and diabetes

Research into constraint-induced movement therapy

Pig tissue may help reduce the damage and disability of stroke

Ramipril reduces rate of sudden cardiac death and nonfatal cardiac arrest by 21 percent

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News